Skip to main content

letter

. 1994 Mar 5;308(6929):653. doi: 10.1136/bmj.308.6929.653a

Gangliosides and Guillain-Barré syndrome. No causal link.

J C Samson, M G Fiori

PMCID: PMC2539694 PMID: 8148723

653

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Beghi E., Kurland L. T., Mulder D. W., Wiederholt W. C. Guillain-Barré syndrome. Clinicoepidemiologic features and effect of influenza vaccine. Arch Neurol. 1985 Nov;42(11):1053–1057. doi: 10.1001/archneur.1985.04060100035016. [DOI] [PubMed] [Google Scholar]
George J., Twomey J. A. Causes of polyneuropathy in the elderly. Age Ageing. 1986 Jul;15(4):247–249. doi: 10.1093/ageing/15.4.247. [DOI] [PubMed] [Google Scholar]
Granieri E., Casetta I., Govoni V., Tola M. R., Paolino E., Rocca W. A. Ganglioside therapy and Guillain-Barré syndrome. A historical cohort study in Ferrara, Italy, fails to demonstrate an association. Neuroepidemiology. 1991;10(4):161–169. doi: 10.1159/000110265. [DOI] [PubMed] [Google Scholar]
Hallas J., Halls J., Bredkjaer C., Friis M. L. Guillain-Barré syndrome: diagnostic criteria, epidemiology, clinical course and prognosis. Acta Neurol Scand. 1988 Aug;78(2):118–122. doi: 10.1111/j.1600-0404.1988.tb03632.x. [DOI] [PubMed] [Google Scholar]
Landi G., D'Alessandro R., Dossi B. C., Ricci S., Simone I. L., Ciccone A. Guillain-Barré syndrome after exogenous gangliosides in Italy. BMJ. 1993 Dec 4;307(6917):1463–1464. doi: 10.1136/bmj.307.6917.1463. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES